Kelly CRISPR & Gene Editing Technology ETF XDNA
7.38 USD +7.38
Day range unavailable
52-week range unavailable
Kelly CRISPR & Gene Editing Technology ETF
- Issuer
- KellyETFs
- Asset class
- Equity
- Expense ratio
- 0.78%
- Assets under management
- $2.59M
- NAV
- 7.38
- Holdings
- 1
- Inception
- 2022-01-13
- Top 10 weight
- 100.00%
Top holdings
Updated 2024-08-12